Medical Care

Global Viral Safety Testing Market Research Report 2025

The global market for Viral Safety Testing was valued at US$ 848 million in the year 2024 and is projected to reach a revised size of US$ 2131 million by 2031, growing at a CAGR of 15.3% during the forecast period.
Viral safety testing is a critical set of procedures used to detect, quantify, and eliminate the presence of viruses in biological products, especially those intended for human use such as biopharmaceuticals, vaccines, blood products, and gene or cell therapies. This testing ensures that such products are free from contaminating or adventitious viruses, thereby safeguarding patient health and ensuring compliance with regulatory standards.
North American market for Viral Safety Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Viral Safety Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Viral Safety Testing in Biopharmaceuticals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Viral Safety Testing include Charles River, Eurofins BioPharma, Clean Cells, Texcell, Merck Millipore, Syngene, CPHI Online, Nelson Labs, Sartorius Stedim BioOutsource Limited, WuXi Biologics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Viral Safety Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Safety Testing.
The Viral Safety Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Viral Safety Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Viral Safety Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River
Eurofins BioPharma
Clean Cells
Texcell
Merck Millipore
Syngene
CPHI Online
Nelson Labs
Sartorius Stedim BioOutsource Limited
WuXi Biologics
ViSpot Co., Ltd.
Syngene International Ltd.
Laboratory Corporation of America Holdings
Creative Biogene
Asahi Kasei Corporation
Segment by Type
Adventitious Virus Tests
Antibody Production Tests
Retrovirus Tests
Specific Virus Tests
Segment by Application
Biopharmaceuticals
Medical Industry
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Viral Safety Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Safety Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Adventitious Virus Tests
1.2.3 Antibody Production Tests
1.2.4 Retrovirus Tests
1.2.5 Specific Virus Tests
1.3 Market by Application
1.3.1 Global Viral Safety Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biopharmaceuticals
1.3.3 Medical Industry
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Safety Testing Market Perspective (2020-2031)
2.2 Global Viral Safety Testing Growth Trends by Region
2.2.1 Global Viral Safety Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Viral Safety Testing Historic Market Size by Region (2020-2025)
2.2.3 Viral Safety Testing Forecasted Market Size by Region (2026-2031)
2.3 Viral Safety Testing Market Dynamics
2.3.1 Viral Safety Testing Industry Trends
2.3.2 Viral Safety Testing Market Drivers
2.3.3 Viral Safety Testing Market Challenges
2.3.4 Viral Safety Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Safety Testing Players by Revenue
3.1.1 Global Top Viral Safety Testing Players by Revenue (2020-2025)
3.1.2 Global Viral Safety Testing Revenue Market Share by Players (2020-2025)
3.2 Global Top Viral Safety Testing Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Viral Safety Testing Revenue
3.4 Global Viral Safety Testing Market Concentration Ratio
3.4.1 Global Viral Safety Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Safety Testing Revenue in 2024
3.5 Global Key Players of Viral Safety Testing Head office and Area Served
3.6 Global Key Players of Viral Safety Testing, Product and Application
3.7 Global Key Players of Viral Safety Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Safety Testing Breakdown Data by Type
4.1 Global Viral Safety Testing Historic Market Size by Type (2020-2025)
4.2 Global Viral Safety Testing Forecasted Market Size by Type (2026-2031)
5 Viral Safety Testing Breakdown Data by Application
5.1 Global Viral Safety Testing Historic Market Size by Application (2020-2025)
5.2 Global Viral Safety Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Viral Safety Testing Market Size (2020-2031)
6.2 North America Viral Safety Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Viral Safety Testing Market Size by Country (2020-2025)
6.4 North America Viral Safety Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral Safety Testing Market Size (2020-2031)
7.2 Europe Viral Safety Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Viral Safety Testing Market Size by Country (2020-2025)
7.4 Europe Viral Safety Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Safety Testing Market Size (2020-2031)
8.2 Asia-Pacific Viral Safety Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Viral Safety Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Viral Safety Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral Safety Testing Market Size (2020-2031)
9.2 Latin America Viral Safety Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Viral Safety Testing Market Size by Country (2020-2025)
9.4 Latin America Viral Safety Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Safety Testing Market Size (2020-2031)
10.2 Middle East & Africa Viral Safety Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Viral Safety Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Viral Safety Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Details
11.1.2 Charles River Business Overview
11.1.3 Charles River Viral Safety Testing Introduction
11.1.4 Charles River Revenue in Viral Safety Testing Business (2020-2025)
11.1.5 Charles River Recent Development
11.2 Eurofins BioPharma
11.2.1 Eurofins BioPharma Company Details
11.2.2 Eurofins BioPharma Business Overview
11.2.3 Eurofins BioPharma Viral Safety Testing Introduction
11.2.4 Eurofins BioPharma Revenue in Viral Safety Testing Business (2020-2025)
11.2.5 Eurofins BioPharma Recent Development
11.3 Clean Cells
11.3.1 Clean Cells Company Details
11.3.2 Clean Cells Business Overview
11.3.3 Clean Cells Viral Safety Testing Introduction
11.3.4 Clean Cells Revenue in Viral Safety Testing Business (2020-2025)
11.3.5 Clean Cells Recent Development
11.4 Texcell
11.4.1 Texcell Company Details
11.4.2 Texcell Business Overview
11.4.3 Texcell Viral Safety Testing Introduction
11.4.4 Texcell Revenue in Viral Safety Testing Business (2020-2025)
11.4.5 Texcell Recent Development
11.5 Merck Millipore
11.5.1 Merck Millipore Company Details
11.5.2 Merck Millipore Business Overview
11.5.3 Merck Millipore Viral Safety Testing Introduction
11.5.4 Merck Millipore Revenue in Viral Safety Testing Business (2020-2025)
11.5.5 Merck Millipore Recent Development
11.6 Syngene
11.6.1 Syngene Company Details
11.6.2 Syngene Business Overview
11.6.3 Syngene Viral Safety Testing Introduction
11.6.4 Syngene Revenue in Viral Safety Testing Business (2020-2025)
11.6.5 Syngene Recent Development
11.7 CPHI Online
11.7.1 CPHI Online Company Details
11.7.2 CPHI Online Business Overview
11.7.3 CPHI Online Viral Safety Testing Introduction
11.7.4 CPHI Online Revenue in Viral Safety Testing Business (2020-2025)
11.7.5 CPHI Online Recent Development
11.8 Nelson Labs
11.8.1 Nelson Labs Company Details
11.8.2 Nelson Labs Business Overview
11.8.3 Nelson Labs Viral Safety Testing Introduction
11.8.4 Nelson Labs Revenue in Viral Safety Testing Business (2020-2025)
11.8.5 Nelson Labs Recent Development
11.9 Sartorius Stedim BioOutsource Limited
11.9.1 Sartorius Stedim BioOutsource Limited Company Details
11.9.2 Sartorius Stedim BioOutsource Limited Business Overview
11.9.3 Sartorius Stedim BioOutsource Limited Viral Safety Testing Introduction
11.9.4 Sartorius Stedim BioOutsource Limited Revenue in Viral Safety Testing Business (2020-2025)
11.9.5 Sartorius Stedim BioOutsource Limited Recent Development
11.10 WuXi Biologics
11.10.1 WuXi Biologics Company Details
11.10.2 WuXi Biologics Business Overview
11.10.3 WuXi Biologics Viral Safety Testing Introduction
11.10.4 WuXi Biologics Revenue in Viral Safety Testing Business (2020-2025)
11.10.5 WuXi Biologics Recent Development
11.11 ViSpot Co., Ltd.
11.11.1 ViSpot Co., Ltd. Company Details
11.11.2 ViSpot Co., Ltd. Business Overview
11.11.3 ViSpot Co., Ltd. Viral Safety Testing Introduction
11.11.4 ViSpot Co., Ltd. Revenue in Viral Safety Testing Business (2020-2025)
11.11.5 ViSpot Co., Ltd. Recent Development
11.12 Syngene International Ltd.
11.12.1 Syngene International Ltd. Company Details
11.12.2 Syngene International Ltd. Business Overview
11.12.3 Syngene International Ltd. Viral Safety Testing Introduction
11.12.4 Syngene International Ltd. Revenue in Viral Safety Testing Business (2020-2025)
11.12.5 Syngene International Ltd. Recent Development
11.13 Laboratory Corporation of America Holdings
11.13.1 Laboratory Corporation of America Holdings Company Details
11.13.2 Laboratory Corporation of America Holdings Business Overview
11.13.3 Laboratory Corporation of America Holdings Viral Safety Testing Introduction
11.13.4 Laboratory Corporation of America Holdings Revenue in Viral Safety Testing Business (2020-2025)
11.13.5 Laboratory Corporation of America Holdings Recent Development
11.14 Creative Biogene
11.14.1 Creative Biogene Company Details
11.14.2 Creative Biogene Business Overview
11.14.3 Creative Biogene Viral Safety Testing Introduction
11.14.4 Creative Biogene Revenue in Viral Safety Testing Business (2020-2025)
11.14.5 Creative Biogene Recent Development
11.15 Asahi Kasei Corporation
11.15.1 Asahi Kasei Corporation Company Details
11.15.2 Asahi Kasei Corporation Business Overview
11.15.3 Asahi Kasei Corporation Viral Safety Testing Introduction
11.15.4 Asahi Kasei Corporation Revenue in Viral Safety Testing Business (2020-2025)
11.15.5 Asahi Kasei Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Viral Safety Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Adventitious Virus Tests
Table 3. Key Players of Antibody Production Tests
Table 4. Key Players of Retrovirus Tests
Table 5. Key Players of Specific Virus Tests
Table 6. Global Viral Safety Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Viral Safety Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Viral Safety Testing Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Viral Safety Testing Market Share by Region (2020-2025)
Table 10. Global Viral Safety Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Viral Safety Testing Market Share by Region (2026-2031)
Table 12. Viral Safety Testing Market Trends
Table 13. Viral Safety Testing Market Drivers
Table 14. Viral Safety Testing Market Challenges
Table 15. Viral Safety Testing Market Restraints
Table 16. Global Viral Safety Testing Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Viral Safety Testing Market Share by Players (2020-2025)
Table 18. Global Top Viral Safety Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Safety Testing as of 2024)
Table 19. Ranking of Global Top Viral Safety Testing Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Viral Safety Testing Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Viral Safety Testing, Headquarters and Area Served
Table 22. Global Key Players of Viral Safety Testing, Product and Application
Table 23. Global Key Players of Viral Safety Testing, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Viral Safety Testing Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Viral Safety Testing Revenue Market Share by Type (2020-2025)
Table 27. Global Viral Safety Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Viral Safety Testing Revenue Market Share by Type (2026-2031)
Table 29. Global Viral Safety Testing Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Viral Safety Testing Revenue Market Share by Application (2020-2025)
Table 31. Global Viral Safety Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Viral Safety Testing Revenue Market Share by Application (2026-2031)
Table 33. North America Viral Safety Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Viral Safety Testing Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Viral Safety Testing Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Viral Safety Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Viral Safety Testing Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Viral Safety Testing Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Viral Safety Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Viral Safety Testing Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Viral Safety Testing Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Viral Safety Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Viral Safety Testing Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Viral Safety Testing Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Viral Safety Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Viral Safety Testing Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Viral Safety Testing Market Size by Country (2026-2031) & (US$ Million)
Table 48. Charles River Company Details
Table 49. Charles River Business Overview
Table 50. Charles River Viral Safety Testing Product
Table 51. Charles River Revenue in Viral Safety Testing Business (2020-2025) & (US$ Million)
Table 52. Charles River Recent Development
Table 53. Eurofins BioPharma Company Details
Table 54. Eurofins BioPharma Business Overview
Table 55. Eurofins BioPharma Viral Safety Testing Product
Table 56. Eurofins BioPharma Revenue in Viral Safety Testing Business (2020-2025) & (US$ Million)
Table 57. Eurofins BioPharma Recent Development
Table 58. Clean Cells Company Details
Table 59. Clean Cells Business Overview
Table 60. Clean Cells Viral Safety Testing Product
Table 61. Clean Cells Revenue in Viral Safety Testing Business (2020-2025) & (US$ Million)
Table 62. Clean Cells Recent Development
Table 63. Texcell Company Details
Table 64. Texcell Business Overview
Table 65. Texcell Viral Safety Testing Product
Table 66. Texcell Revenue in Viral Safety Testing Business (2020-2025) & (US$ Million)
Table 67. Texcell Recent Development
Table 68. Merck Millipore Company Details
Table 69. Merck Millipore Business Overview
Table 70. Merck Millipore Viral Safety Testing Product
Table 71. Merck Millipore Revenue in Viral Safety Testing Business (2020-2025) & (US$ Million)
Table 72. Merck Millipore Recent Development
Table 73. Syngene Company Details
Table 74. Syngene Business Overview
Table 75. Syngene Viral Safety Testing Product
Table 76. Syngene Revenue in Viral Safety Testing Business (2020-2025) & (US$ Million)
Table 77. Syngene Recent Development
Table 78. CPHI Online Company Details
Table 79. CPHI Online Business Overview
Table 80. CPHI Online Viral Safety Testing Product
Table 81. CPHI Online Revenue in Viral Safety Testing Business (2020-2025) & (US$ Million)
Table 82. CPHI Online Recent Development
Table 83. Nelson Labs Company Details
Table 84. Nelson Labs Business Overview
Table 85. Nelson Labs Viral Safety Testing Product
Table 86. Nelson Labs Revenue in Viral Safety Testing Business (2020-2025) & (US$ Million)
Table 87. Nelson Labs Recent Development
Table 88. Sartorius Stedim BioOutsource Limited Company Details
Table 89. Sartorius Stedim BioOutsource Limited Business Overview
Table 90. Sartorius Stedim BioOutsource Limited Viral Safety Testing Product
Table 91. Sartorius Stedim BioOutsource Limited Revenue in Viral Safety Testing Business (2020-2025) & (US$ Million)
Table 92. Sartorius Stedim BioOutsource Limited Recent Development
Table 93. WuXi Biologics Company Details
Table 94. WuXi Biologics Business Overview
Table 95. WuXi Biologics Viral Safety Testing Product
Table 96. WuXi Biologics Revenue in Viral Safety Testing Business (2020-2025) & (US$ Million)
Table 97. WuXi Biologics Recent Development
Table 98. ViSpot Co., Ltd. Company Details
Table 99. ViSpot Co., Ltd. Business Overview
Table 100. ViSpot Co., Ltd. Viral Safety Testing Product
Table 101. ViSpot Co., Ltd. Revenue in Viral Safety Testing Business (2020-2025) & (US$ Million)
Table 102. ViSpot Co., Ltd. Recent Development
Table 103. Syngene International Ltd. Company Details
Table 104. Syngene International Ltd. Business Overview
Table 105. Syngene International Ltd. Viral Safety Testing Product
Table 106. Syngene International Ltd. Revenue in Viral Safety Testing Business (2020-2025) & (US$ Million)
Table 107. Syngene International Ltd. Recent Development
Table 108. Laboratory Corporation of America Holdings Company Details
Table 109. Laboratory Corporation of America Holdings Business Overview
Table 110. Laboratory Corporation of America Holdings Viral Safety Testing Product
Table 111. Laboratory Corporation of America Holdings Revenue in Viral Safety Testing Business (2020-2025) & (US$ Million)
Table 112. Laboratory Corporation of America Holdings Recent Development
Table 113. Creative Biogene Company Details
Table 114. Creative Biogene Business Overview
Table 115. Creative Biogene Viral Safety Testing Product
Table 116. Creative Biogene Revenue in Viral Safety Testing Business (2020-2025) & (US$ Million)
Table 117. Creative Biogene Recent Development
Table 118. Asahi Kasei Corporation Company Details
Table 119. Asahi Kasei Corporation Business Overview
Table 120. Asahi Kasei Corporation Viral Safety Testing Product
Table 121. Asahi Kasei Corporation Revenue in Viral Safety Testing Business (2020-2025) & (US$ Million)
Table 122. Asahi Kasei Corporation Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report


List of Figures
Figure 1. Viral Safety Testing Picture
Figure 2. Global Viral Safety Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Viral Safety Testing Market Share by Type: 2024 VS 2031
Figure 4. Adventitious Virus Tests Features
Figure 5. Antibody Production Tests Features
Figure 6. Retrovirus Tests Features
Figure 7. Specific Virus Tests Features
Figure 8. Global Viral Safety Testing Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Viral Safety Testing Market Share by Application: 2024 VS 2031
Figure 10. Biopharmaceuticals Case Studies
Figure 11. Medical Industry Case Studies
Figure 12. Others Case Studies
Figure 13. Viral Safety Testing Report Years Considered
Figure 14. Global Viral Safety Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Viral Safety Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Viral Safety Testing Market Share by Region: 2024 VS 2031
Figure 17. Global Viral Safety Testing Market Share by Players in 2024
Figure 18. Global Viral Safety Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Viral Safety Testing Revenue in 2024
Figure 20. North America Viral Safety Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Viral Safety Testing Market Share by Country (2020-2031)
Figure 22. United States Viral Safety Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Viral Safety Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Viral Safety Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Viral Safety Testing Market Share by Country (2020-2031)
Figure 26. Germany Viral Safety Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Viral Safety Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Viral Safety Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Viral Safety Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Viral Safety Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Viral Safety Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Viral Safety Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Viral Safety Testing Market Share by Region (2020-2031)
Figure 34. China Viral Safety Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Viral Safety Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Viral Safety Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Viral Safety Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Viral Safety Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Viral Safety Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Viral Safety Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Viral Safety Testing Market Share by Country (2020-2031)
Figure 42. Mexico Viral Safety Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Viral Safety Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Viral Safety Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Viral Safety Testing Market Share by Country (2020-2031)
Figure 46. Turkey Viral Safety Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Viral Safety Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Viral Safety Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Charles River Revenue Growth Rate in Viral Safety Testing Business (2020-2025)
Figure 50. Eurofins BioPharma Revenue Growth Rate in Viral Safety Testing Business (2020-2025)
Figure 51. Clean Cells Revenue Growth Rate in Viral Safety Testing Business (2020-2025)
Figure 52. Texcell Revenue Growth Rate in Viral Safety Testing Business (2020-2025)
Figure 53. Merck Millipore Revenue Growth Rate in Viral Safety Testing Business (2020-2025)
Figure 54. Syngene Revenue Growth Rate in Viral Safety Testing Business (2020-2025)
Figure 55. CPHI Online Revenue Growth Rate in Viral Safety Testing Business (2020-2025)
Figure 56. Nelson Labs Revenue Growth Rate in Viral Safety Testing Business (2020-2025)
Figure 57. Sartorius Stedim BioOutsource Limited Revenue Growth Rate in Viral Safety Testing Business (2020-2025)
Figure 58. WuXi Biologics Revenue Growth Rate in Viral Safety Testing Business (2020-2025)
Figure 59. ViSpot Co., Ltd. Revenue Growth Rate in Viral Safety Testing Business (2020-2025)
Figure 60. Syngene International Ltd. Revenue Growth Rate in Viral Safety Testing Business (2020-2025)
Figure 61. Laboratory Corporation of America Holdings Revenue Growth Rate in Viral Safety Testing Business (2020-2025)
Figure 62. Creative Biogene Revenue Growth Rate in Viral Safety Testing Business (2020-2025)
Figure 63. Asahi Kasei Corporation Revenue Growth Rate in Viral Safety Testing Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies